Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Dopamine -- Agonists"" wg kryterium: Temat


Tytuł:
Dopamine D4 Receptor Agonist Drastically Increases Delta Activity in the Thalamic Nucleus Reuniens: Potential Role in Communication between Prefrontal Cortex and Hippocampus.
Autorzy:
Kuang J; Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Kafetzopoulos V; Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.; Department of Psychiatry, Medical School, University of Ioannina, 45110 Ioannina, Greece.
Deth R; Department of Pharmaceutical Sciences, Nova Southeastern University, Fort Lauderdale, FL 33328, USA.
Kocsis B; Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Oct 18; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 18.
Typ publikacji:
Journal Article
MeSH Terms:
Dopamine Agonists*/pharmacology
Receptors, Dopamine D4*
Animals ; Rats ; Hippocampus/metabolism ; Midline Thalamic Nuclei/metabolism ; Prefrontal Cortex/metabolism
Czasopismo naukowe
Tytuł:
Ultra-high-field pharmacological functional MRI of dopamine D1 receptor-related interventions in anesthetized rats.
Autorzy:
Kimura Y; Drug Development Research Laboratories, Sumitomo Dainippon Pharma Co Ltd, Osaka, Japan.; Graduate School of Science and Technology, Division of Information Science, Nara Institute of Science and Technology (NAIST), Ikoma, Japan.
Nakazawa S; Drug Development Research Laboratories, Sumitomo Dainippon Pharma Co Ltd, Osaka, Japan.
Nishigori K; Drug Development Research Laboratories, Sumitomo Dainippon Pharma Co Ltd, Osaka, Japan.
Mori Y; Center for Information and Neural Networks (CiNet), National Institute of Information and Communications Technology, Osaka University, Osaka, Japan.; Biofunctional Imaging Laboratory, Immunology Frontier Research Center (IFReC), Osaka University, Osaka, Japan.
Ichihara J; Drug Development Research Laboratories, Sumitomo Dainippon Pharma Co Ltd, Osaka, Japan.
Yoshioka Y; Center for Information and Neural Networks (CiNet), National Institute of Information and Communications Technology, Osaka University, Osaka, Japan.; Biofunctional Imaging Laboratory, Immunology Frontier Research Center (IFReC), Osaka University, Osaka, Japan.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Apr; Vol. 11 (2), pp. e01055.
Typ publikacji:
Journal Article
MeSH Terms:
Dopamine Agonists*/pharmacology
Isoflurane*/pharmacology
Rats ; Animals ; Receptors, Dopamine D1/metabolism ; Brain ; Magnetic Resonance Imaging
Czasopismo naukowe
Tytuł:
Behavioural effects of APH199, a selective dopamine D4 receptor agonist, in animal models.
Autorzy:
Chestnykh D; Department of Psychiatry and Psychotherapy, University Clinic, Friedrich-Alexander-University of Erlangen-Nuremberg, Schwabachanlage 6, 91054, Erlangen, Germany.
Graßl F; Department of Chemistry and Pharmacy, Friedrich-Alexander-University of Erlangen-Nuremberg, Nikolaus-Fiebiger-Str. 10, 91058, Erlangen, Germany.
Pfeifer C; Department of Psychiatry and Psychotherapy, University Clinic, Friedrich-Alexander-University of Erlangen-Nuremberg, Schwabachanlage 6, 91054, Erlangen, Germany.
Dülk J; Department of Psychiatry and Psychotherapy, University Clinic, Friedrich-Alexander-University of Erlangen-Nuremberg, Schwabachanlage 6, 91054, Erlangen, Germany.
Ebner C; Department of Psychiatry and Psychotherapy, University Clinic, Friedrich-Alexander-University of Erlangen-Nuremberg, Schwabachanlage 6, 91054, Erlangen, Germany.
Walters M; Department of Psychiatry and Psychotherapy, University Clinic, Friedrich-Alexander-University of Erlangen-Nuremberg, Schwabachanlage 6, 91054, Erlangen, Germany.
von Hörsten S; Department of Experimental Therapy, Preclinical Experimental Center, Friedrich-Alexander-University of Erlangen-Nuremberg, Palmsanlage 5, 91054, Erlangen, Germany.
Kornhuber J; Department of Psychiatry and Psychotherapy, University Clinic, Friedrich-Alexander-University of Erlangen-Nuremberg, Schwabachanlage 6, 91054, Erlangen, Germany.
Kalinichenko LS; Department of Psychiatry and Psychotherapy, University Clinic, Friedrich-Alexander-University of Erlangen-Nuremberg, Schwabachanlage 6, 91054, Erlangen, Germany.
Heinrich M; Department of Chemistry and Pharmacy, Friedrich-Alexander-University of Erlangen-Nuremberg, Nikolaus-Fiebiger-Str. 10, 91058, Erlangen, Germany.
Müller CP; Department of Psychiatry and Psychotherapy, University Clinic, Friedrich-Alexander-University of Erlangen-Nuremberg, Schwabachanlage 6, 91054, Erlangen, Germany. .; Centre for Drug Research, University Sains Malaysia, Penang, Minden, Malaysia. .
Pokaż więcej
Źródło:
Psychopharmacology [Psychopharmacology (Berl)] 2023 Apr; Vol. 240 (4), pp. 1011-1031. Date of Electronic Publication: 2023 Feb 28.
Typ publikacji:
Journal Article
MeSH Terms:
Receptors, Dopamine D4*
Dopamine Agonists*/pharmacology
Mice ; Rats ; Male ; Animals ; Reflex, Startle ; Rats, Sprague-Dawley ; Mice, Inbred C57BL ; Amphetamine/pharmacology ; Models, Animal ; Behavior, Animal
Czasopismo naukowe
Tytuł:
Apomorphine is a potent inhibitor of ferroptosis independent of dopaminergic receptors.
Autorzy:
Miyauchi A; Department of Pediatrics, Jichi Medical University, Shimotsuke, Japan. .
Watanabe C; Department of Pediatrics, Jichi Medical University, Shimotsuke, Japan.
Yamada N; Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan.
Jimbo EF; Department of Pediatrics, Jichi Medical University, Shimotsuke, Japan.
Kobayashi M; Department of Pediatrics, Jichi Medical University, Shimotsuke, Japan.
Ohishi N; Department of Pediatrics, Jichi Medical University, Shimotsuke, Japan.
Nagayoshi A; Department of Pediatrics, Jichi Medical University, Shimotsuke, Japan.
Aoki S; Department of Pediatrics, Jichi Medical University, Shimotsuke, Japan.
Kishita Y; Diagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Tokyo, Japan.; Department of Life Science, Faculty of Science and Engineering, Kindai University, Osaka, Japan.
Ohtake A; Department of Clinical Genomics & Pediatrics (Faculty of Medicine), Saitama Medical University, Saitama, Japan.; Center for Intractable Diseases, Saitama Medical University Hospital, Saitama, Japan.
Ohno N; Department of Anatomy, Division of Histology and Cell Biology, School of Medicine, Jichi Medical University, Shimotsuke, Japan.; Division of Ultrastructural Research, National Institute for Physiological Sciences, Okazaki, Japan.
Takahashi M; Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan.
Yamagata T; Department of Pediatrics, Jichi Medical University, Shimotsuke, Japan.
Osaka H; Department of Pediatrics, Jichi Medical University, Shimotsuke, Japan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 27; Vol. 14 (1), pp. 4820. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Ferroptosis*
Mitochondrial Diseases*
Humans ; Apomorphine/pharmacology ; Cyclooxygenase 2/genetics ; Receptors, Dopamine D2/metabolism ; Dopamine Agonists/pharmacology
Czasopismo naukowe
Tytuł:
Dopamine-Depleted Dopamine Transporter Knockout (DDD) Mice: Dyskinesia with L-DOPA and Dopamine D1 Agonists.
Autorzy:
Pogorelov VM; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, 354 Sands Building, 303 Research Drive, Durham, NC 27710, USA.
Martini ML; Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Jin J; Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Wetsel WC; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, 354 Sands Building, 303 Research Drive, Durham, NC 27710, USA.; Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA.; Department of Neurobiology, Duke University Medical Center, Durham, NC 27710, USA.
Caron MG; Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2023 Nov 17; Vol. 13 (11). Date of Electronic Publication: 2023 Nov 17.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Dyskinesia, Drug-Induced*/drug therapy
Parkinson Disease*/drug therapy
Parkinson Disease*/genetics
Mice ; Animals ; Levodopa/pharmacology ; Levodopa/therapeutic use ; Dopamine Agonists/pharmacology ; Dopamine Agonists/therapeutic use ; Dopamine ; Dopamine Plasma Membrane Transport Proteins/genetics ; Mice, Knockout ; Amantadine/pharmacology
Czasopismo naukowe
Tytuł:
Streptozotocin-induced diabetes in rats modifies the role D 2 , D 3 and D 4 dopamine receptors play in cardiac sympathetic inhibition.
Autorzy:
Rivera-Mancilla E; Department of Pharmacobiology, Cinvestav-Coapa, Mexico City, Mexico.
Altamirano-Espinoza AH; Department of Pharmacobiology, Cinvestav-Coapa, Mexico City, Mexico.
Manrique-Maldonado G; Department of Pharmacobiology, Cinvestav-Coapa, Mexico City, Mexico.
Villanueva-Castillo B; Department of Pharmacobiology, Cinvestav-Coapa, Mexico City, Mexico.
Villalón CM; Department of Pharmacobiology, Cinvestav-Coapa, Mexico City, Mexico.
Pokaż więcej
Źródło:
Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2022 Oct; Vol. 131 (4), pp. 262-269. Date of Electronic Publication: 2022 Jul 22.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Experimental*
Dopamine Agonists*/pharmacology
Animals ; Dopamine ; Male ; Quinpirole/pharmacology ; Rats ; Rats, Wistar ; Receptors, Dopamine D1 ; Receptors, Dopamine D2/metabolism ; Streptozocin
Czasopismo naukowe
Tytuł:
Does cabergoline administration affect endometrial VEGFR-2 expression in a rat model of ovarian hyperstimulation syndrome?
Autorzy:
Yilmaz N; Department of Reproductive Endocrinology, Zekai Tahir Burak Women's Health Education and Research Hospital, University of Health Sciences, Ankara, Turkey.
Gulsen Coban P; Department of Obstetric and Gynecology, Zekai Tahir Burak Women's Health Education and Research Hospital, University of Health Sciences, Ankara, Turkey.
Yilmaz S; Department of Obstetric and Gynecology, Zekai Tahir Burak Women's Health Education and Research Hospital, University of Health Sciences, Ankara, Turkey.
Inal HA; Department of Reproductive Endocrinology, Antalya Training and Research Hospital, University of Health Sciences, Antalya, Turkey.
Timur H; Department of Obstetric and Gynecology, Zekai Tahir Burak Women's Health Education and Research Hospital, University of Health Sciences, Ankara, Turkey.
Haltas H; Department of Pathology, Private Hospital, Ankara, Turkey.
Pokaż więcej
Źródło:
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology [Gynecol Endocrinol] 2023 Dec; Vol. 39 (1), pp. 2217295.
Typ publikacji:
Journal Article
MeSH Terms:
Ovarian Hyperstimulation Syndrome*/chemically induced
Ovarian Hyperstimulation Syndrome*/drug therapy
Animals ; Female ; Rats ; Cabergoline/therapeutic use ; Dopamine Agonists/therapeutic use ; Ergolines/pharmacology ; Rats, Wistar ; Vascular Endothelial Growth Factor A ; Vascular Endothelial Growth Factor Receptor-2/therapeutic use
Czasopismo naukowe
Tytuł:
Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trial.
Autorzy:
Buchfuhrer MJ; Stanford University School of Medicine, Stanford, CA, USA.; Private Practice, Downey, CA, USA.
Roy A; Ohio Sleep Medicine Institute, Dublin, OH, USA.
Rodriguez S; Private Practice, Downey, CA, USA.; Department of Clinical Research, Noctrix Health, Inc, Pleasanton, CA, USA.
Charlesworth JD; Department of Clinical Research, Noctrix Health, Inc, Pleasanton, CA, USA. .
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2023 Nov 21; Vol. 23 (1), pp. 415. Date of Electronic Publication: 2023 Nov 21.
Typ publikacji:
Clinical Trial; Journal Article
MeSH Terms:
Analgesics, Opioid*/therapeutic use
Restless Legs Syndrome*/drug therapy
Adult ; Humans ; Dopamine Agonists/adverse effects ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Ergot Alkaloids on Cereals and Seeds: Analytical Methods, Occurrence, and Future Perspectives.
Autorzy:
Silva Â; University of Coimbra, Faculty of Pharmacy, Polo III, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal.
Mateus ARS; University of Coimbra, Faculty of Pharmacy, Polo III, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal.; National Institute for Agricultural and Veterinary Research (INIAV), I.P., 4485-655 Vila do Conde, Portugal.
Barros SC; National Institute for Agricultural and Veterinary Research (INIAV), I.P., 4485-655 Vila do Conde, Portugal.
Silva AS; University of Coimbra, Faculty of Pharmacy, Polo III, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal.; Center for Study in Animal Science (CECA), ICETA, University of Oporto, 4501-401 Oporto, Portugal.; Associate Laboratory for Animal and Veterinary Sciences (AL4AnimalS), 1300-477 Lisbon, Portugal.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Oct 23; Vol. 28 (20). Date of Electronic Publication: 2023 Oct 23.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Ergot Alkaloids*
Mycotoxins*/analysis
Claviceps*
Humans ; Edible Grain/chemistry ; Heterocyclic Compounds, 4 or More Rings ; Dopamine Agonists ; Food Contamination/analysis
Czasopismo naukowe
Tytuł:
Phosphodiesterase 10A (PDE10A): Regulator of Dopamine Agonist-Induced Gene Expression in the Striatum.
Autorzy:
Bonate R; Stanson Toshok Center for Brain Function and Repair, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.
Kurek G; Stanson Toshok Center for Brain Function and Repair, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.
Hrabak M; Stanson Toshok Center for Brain Function and Repair, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.
Patterson S; Stanson Toshok Center for Brain Function and Repair, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.
Padovan-Neto F; Discipline of Neuroscience, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.
West AR; Discipline of Neuroscience, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.; Center for Neurodegenerative Disease & Therapeutics, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.
Steiner H; Stanson Toshok Center for Brain Function and Repair, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.; Discipline of Cellular and Molecular Pharmacology, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.
Pokaż więcej
Źródło:
Cells [Cells] 2022 Jul 16; Vol. 11 (14). Date of Electronic Publication: 2022 Jul 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Dopamine*/metabolism
Dopamine Agonists*/pharmacology
Gene Expression ; Nucleotides, Cyclic ; Phosphoric Diester Hydrolases/genetics ; Phosphoric Diester Hydrolases/metabolism ; Receptors, Dopamine D1/metabolism
Czasopismo naukowe
Tytuł:
Ropinirole Cotreatment Prevents Perivascular Glial Recruitment in a Rat Model of L-DOPA-Induced Dyskinesia.
Autorzy:
Elabi OF; Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden.
Espa E; Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden.
Skovgård K; Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden.
Fanni S; Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden.
Cenci MA; Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Jul 14; Vol. 12 (14). Date of Electronic Publication: 2023 Jul 14.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Levodopa*
Dyskinesia, Drug-Induced*/drug therapy
Rats ; Animals ; Antiparkinson Agents/adverse effects ; Microglia/metabolism ; Dopamine ; Dopamine Agonists/pharmacology ; Dopamine Agonists/therapeutic use
Czasopismo naukowe
Tytuł:
Permeability of dopamine D2 receptor agonist hordenine across the intestinal and blood-brain barrier in vitro.
Autorzy:
Hahn M; Institute of Food Chemistry, Westfälische Wilhelms-Universität Münster, Münster, Germany.
Lindemann V; Institute of Food Chemistry, Westfälische Wilhelms-Universität Münster, Münster, Germany.
Behrens M; Institute of Food Chemistry, Westfälische Wilhelms-Universität Münster, Münster, Germany.
Mulac D; Institute of Pharmaceutical Technology and Biopharmacy, Westfälische Wilhelms-Universität Münster, Münster, Germany.
Langer K; Institute of Pharmaceutical Technology and Biopharmacy, Westfälische Wilhelms-Universität Münster, Münster, Germany.
Esselen M; Institute of Food Chemistry, Westfälische Wilhelms-Universität Münster, Münster, Germany.
Humpf HU; Institute of Food Chemistry, Westfälische Wilhelms-Universität Münster, Münster, Germany.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Jun 16; Vol. 17 (6), pp. e0269486. Date of Electronic Publication: 2022 Jun 16 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Blood-Brain Barrier*/metabolism
Dopamine Agonists*/pharmacology
Animals ; Caco-2 Cells ; Endothelial Cells/metabolism ; Humans ; Permeability ; Receptors, Dopamine D2/metabolism ; Swine ; Tyramine/analogs & derivatives
Czasopismo naukowe
Tytuł:
The Nitric Oxide (NO) Donor Molsidomine Attenuates Memory Impairments Induced by the D1/D2 Dopaminergic Receptor Agonist Apomorphine in the Rat.
Autorzy:
Vartzoka F; Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, Panepistimiou 3, 415-00 Larissa, Greece.
Ozenoglu E; School of Medicine, University of Acibadem, 415-00 Istanbul, Turkey.
Pitsikas N; Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, Panepistimiou 3, 415-00 Larissa, Greece.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Sep 28; Vol. 28 (19). Date of Electronic Publication: 2023 Sep 28.
Typ publikacji:
Journal Article
MeSH Terms:
Apomorphine*/pharmacology
Clozapine*
Rats ; Animals ; Molsidomine/adverse effects ; Nitric Oxide Donors/pharmacology ; Dopamine Agonists/pharmacology ; Nitric Oxide ; Dopamine ; Risperidone ; Rats, Wistar ; Memory Disorders/drug therapy ; Memory Disorders/chemically induced
Czasopismo naukowe
Tytuł:
Brain Dopamine-Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects.
Autorzy:
Cincotta AH; VeroScience LLC, Tiverton, RI 02878, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Aug 26; Vol. 24 (17). Date of Electronic Publication: 2023 Aug 26.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Diabetes Mellitus, Type 2*/drug therapy
Metabolic Syndrome*/drug therapy
Insulin Resistance*
Cardiovascular Diseases*
Animals ; Bromocriptine ; Dopamine ; Brain ; Insulin, Regular, Human ; Dopamine Agonists ; Insulin
Czasopismo naukowe
Tytuł:
Mechanisms of D1/D2-like dopaminergic agonist, rotigotine, on lower urinary tract function in rat model of Parkinson's disease.
Autorzy:
Ouchi M; Department of Renal and Genitourinary Surgery, Graduate School of Medical Science, Hokkaido University, Kita 15 Nishi 7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan.
Kitta T; Department of Renal and Genitourinary Surgery, Graduate School of Medical Science, Hokkaido University, Kita 15 Nishi 7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan. .
Chiba H; Department of Renal and Genitourinary Surgery, Graduate School of Medical Science, Hokkaido University, Kita 15 Nishi 7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan.
Higuchi M; Department of Renal and Genitourinary Surgery, Graduate School of Medical Science, Hokkaido University, Kita 15 Nishi 7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan.
Togo M; Department of Renal and Genitourinary Surgery, Graduate School of Medical Science, Hokkaido University, Kita 15 Nishi 7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan.
Abe-Takahashi Y; Department of Renal and Genitourinary Surgery, Graduate School of Medical Science, Hokkaido University, Kita 15 Nishi 7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan.
Shinohara N; Department of Renal and Genitourinary Surgery, Graduate School of Medical Science, Hokkaido University, Kita 15 Nishi 7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Mar 16; Vol. 12 (1), pp. 4540. Date of Electronic Publication: 2022 Mar 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Dopamine Agonists*/pharmacology
Parkinson Disease*/drug therapy
Animals ; Disease Models, Animal ; Dopaminergic Neurons ; Female ; Male ; Oxidopamine/pharmacology ; Rats ; Rats, Sprague-Dawley ; Substantia Nigra ; Tetrahydronaphthalenes ; Thiophenes ; Urinary Bladder
Czasopismo naukowe
Tytuł:
Efficacy and safety in the treatment of hyperprolactinemia: A systematic review and network meta-analysis.
Autorzy:
Fachi MM; Federal University of Paraná, Curitiba, Brazil.
de Deus Bueno L; Pequeno Príncipe College, Curitiba, Brazil.
de Oliveira DC; Pequeno Príncipe College, Curitiba, Brazil.
da Silva LL; Pequeno Príncipe College, Curitiba, Brazil.
Bonetti AF; Federal University of Paraná, Curitiba, Brazil.
Pokaż więcej
Źródło:
Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2021 Dec; Vol. 46 (6), pp. 1549-1556. Date of Electronic Publication: 2021 Jun 16.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Dopamine Agonists/*therapeutic use
Hyperprolactinemia/*drug therapy
Hyperprolactinemia/*epidemiology
Dopamine Agonists/administration & dosage ; Dopamine Agonists/adverse effects ; Female ; Galactorrhea/epidemiology ; Humans ; Menstruation Disturbances/epidemiology ; Network Meta-Analysis ; Prolactin/blood ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
Antiangiogenic Effect of Dopamine and Dopaminergic Agonists as an Adjuvant Therapeutic Option in the Treatment of Cancer, Endometriosis, and Osteoarthritis.
Autorzy:
Mendoza-Torreblanca JG; Laboratorio de Neurociencias, Subdirección de Medicina Experimental, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.
Cárdenas-Rodríguez N; Laboratorio de Neurociencias, Subdirección de Medicina Experimental, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.
Carro-Rodríguez J; Laboratorio de Medicina Traslacional Aplicada a Neurociencias, Enfermedades Crónicas y Emergentes, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico.
Contreras-García IJ; Laboratorio de Biología de la Reproducción, Subdirección de Medicina Experimental, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.
Garciadiego-Cázares D; Unidad de Ingeniería de Tejidos, Terapia Celular y Medicina Regenerativa, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City 14389, Mexico.
Ortega-Cuellar D; Laboratorio Nutrición Experimental, Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City 04530, Mexico.
Martínez-López V; Unidad de Ingeniería de Tejidos, Terapia Celular y Medicina Regenerativa, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City 14389, Mexico.
Alfaro-Rodríguez A; Neurociencias Básicas, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Secretaría de Salud, Mexico City 14389, Mexico.
Evia-Ramírez AN; Servicio de Reconstrucción Articular, Cadera y Rodilla, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City 14389, Mexico.
Ignacio-Mejía I; Laboratorio de Medicina Traslacional, Escuela Militar de Graduados de Sanidad, Mexico City 11200, Mexico.
Vargas-Hernández MA; Subdirección de Investigación, Escuela Militar de Graduados de Sanidad, Mexico City 11200, Mexico.
Bandala C; Laboratorio de Medicina Traslacional Aplicada a Neurociencias, Enfermedades Crónicas y Emergentes, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 15; Vol. 24 (12). Date of Electronic Publication: 2023 Jun 15.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Endometriosis*/drug therapy
Neoplasms*/metabolism
Osteoarthritis*/drug therapy
Female ; Humans ; Dopamine Agonists/pharmacology ; Dopamine/metabolism ; Vascular Endothelial Growth Factor Receptor-2/metabolism ; Vascular Endothelial Growth Factor A/metabolism ; Angiogenesis Inhibitors/pharmacology ; Angiogenesis Inhibitors/therapeutic use ; Adjuvants, Immunologic/therapeutic use ; Neovascularization, Pathologic/drug therapy ; Neovascularization, Pathologic/metabolism
Czasopismo naukowe
Tytuł:
Operative treatment of cystic prolactinomas: a retrospective study.
Autorzy:
Su W; Neurosurgery Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
He K; Neurosurgery Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Yang Y; Neurosurgery Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Xu J; Neurosurgery Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Li X; Neurosurgery Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Tang H; Neurosurgery Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Yang J; Neurosurgery Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Yang L; Neurosurgery Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. .
Pokaż więcej
Źródło:
BMC endocrine disorders [BMC Endocr Disord] 2023 May 04; Vol. 23 (1), pp. 99. Date of Electronic Publication: 2023 May 04.
Typ publikacji:
Journal Article
MeSH Terms:
Prolactinoma*/drug therapy
Prolactinoma*/surgery
Pituitary Neoplasms*/surgery
Pituitary Neoplasms*/drug therapy
Humans ; Retrospective Studies ; Treatment Outcome ; Prolactin ; Dopamine Agonists/therapeutic use
Czasopismo naukowe
Tytuł:
Restless legs syndrome in DNAJC12 deficiency.
Autorzy:
Porta F; Department of Pediatrics, AOU Città della Salute e della Scienza di Torino, University of Torino, Turin, Italy. .
Neirotti A; Department of Pediatrics, AOU Città della Salute e della Scienza di Torino, University of Torino, Turin, Italy.
Spada M; Department of Pediatrics, AOU Città della Salute e della Scienza di Torino, University of Torino, Turin, Italy.
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2023 Jun; Vol. 44 (6), pp. 2167-2172. Date of Electronic Publication: 2023 Mar 10.
Typ publikacji:
Journal Article
MeSH Terms:
Restless Legs Syndrome*/complications
Restless Legs Syndrome*/drug therapy
Adult ; Humans ; Dopamine ; Dopamine Agonists/adverse effects ; Levodopa/therapeutic use ; Pramipexole/therapeutic use
Czasopismo naukowe
Tytuł:
Aromatic L-amino acid decarboxylase deficiency in countries in the Middle East: a case series and literature review.
Autorzy:
Abukhaled M; Department of Neurosciences, King Faisal Specialist Hospital and Research Center, (KFSH-RC), Riyadh, Saudi Arabia. abukhaled_.
Al Muqbil M; College of Medicine, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; Division of Pediatric Neurology, Department of Pediatrics, King Abdullah Specialized Children's Hospital, National Guard Health Affairs (NGHA), Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs (MNG-HA), Riyadh, Saudi Arabia.
Alghamdi MA; Medical Genetic Division, Pediatric Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Hundallah K; Division of Neurology, Department of Pediatrics, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Suleiman J; Division of Neurology, Department of Pediatrics, Tawam Hospital, Al Ain, United Arab Emirates.; College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.; American Center for Psychiatry and Neurology, Abu Dhabi, United Arab Emirates.
Ben-Omran T; Sidra Medicine and Research Center, Doha, Qatar.; Hamad Medical Corporation, Doha, Qatar.
Alfadhel M; Department of Genetics and Precision Medicine, Department of Pediatrics, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh, Saudi Arabia.; Medical Genomic Research Department, King Abdullah International Medical Research Centre (KAIMRC), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Ministry of National Guard Health Affairs (MNG-HA), Riyadh, Saudi Arabia.
Almannai M; Department of Genetics and Precision Medicine, Department of Pediatrics, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh, Saudi Arabia.; Medical Genomic Research Department, King Abdullah International Medical Research Centre (KAIMRC), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Ministry of National Guard Health Affairs (MNG-HA), Riyadh, Saudi Arabia.
Alsaleh R; Sidra Medicine and Research Center, Doha, Qatar.
Tabarki B; Division of Neurology, Department of Pediatrics, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Pokaż więcej
Źródło:
European journal of pediatrics [Eur J Pediatr] 2023 Jun; Vol. 182 (6), pp. 2535-2545. Date of Electronic Publication: 2023 Mar 16.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Amino Acid Metabolism, Inborn Errors*/diagnosis
Amino Acid Metabolism, Inborn Errors*/genetics
Amino Acid Metabolism, Inborn Errors*/therapy
Aromatic-L-Amino-Acid Decarboxylases*/genetics
Aromatic-L-Amino-Acid Decarboxylases*/therapeutic use
Humans ; Dopamine Agonists/therapeutic use ; Mutation
SCR Disease Name:
Aromatic amino acid decarboxylase deficiency
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies